Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm, OpGen Ink Deal to Develop Multi-Drug Resistance Test Equipment and Kits

NEW YORK (GenomeWeb) – Fluidigm and OpGen today announced and agreement to collaborate on instruments and kits to test for multi-drug resistance genes in bacteria, fungi, and viruses.

Under the terms of the five-year agreement, the firms will develop tests for the identification, screening, and surveillance of multi-drug resistant pathogens built on Fluidigm's Juno instrument for automating SNP genotyping assays and its Biomark real-time endpoint PCR. The firms will cooperate on quality and regulatory compliance and will have the option to extend the agreement for an additional five years.

"With this expanded relationship, OpGen anticipates developing customized solutions for our CLIA lab customers, strategic partners, and testing laboratories globally," OpGen President Kevin Krenitsky said in a statement, noting that the firm's Acuitas MDRO Gene Test and Resistome Test use Fluidigm's microfluidics.

Steve McPhail, Fluidigm's general manager for production genomics, said, that the partners will seek government funding to develop new products, including molecular information analytics, based on each other's technologies.

Gaithersburg, Maryland-based OpGen, which went public in May, offers molecular testing and informatics to help healthcare organizations fight drug-resistant pathogens. 

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.